Human (allogeneic) iPS cell derived-cardiomyocyte sheet transplantation

3 trials

Sponsors

Miyagawa Shigeru, Osaka University

Conditions

Dilated cardiomyopathyIschemic cardiomyopathy

Phase 1

Clinical trial of human (allogeneic) induced pluripotent stem cell-derived cardiomyocyte sheet for severe cardiomyopathy

Active, not recruitingJPRN-UMIN000032989

Osaka UniversityIschemic cardiomyopathy

Start: 2019-08-11Target: 3Updated: 2026-06-29

Clinical trial of human (allogeneic) iPS cell-derived cardiomyocytes sheet for ischemic cardiomyopathy

Active, not recruitingJPRN-jRCT2053190081

Miyagawa ShigeruIschemic cardiomyopathy

Start: 2020-01-10Target: 10Updated: 2026-06-29

Clinical trial of human (allogeneic) iPS cell-derived cardiomyocytes sheet for dilated cardiomyopathy

Active, not recruitingJPRN-jRCT2053230136

Miyagawa ShigeruDilated cardiomyopathy

Start: 2024-05-13Target: 4Updated: 2026-06-29

Related Papers

Abstract 4138738: Clinical Evidence of Immune Response to Transplanted Allogeneic iPS Cell-Derived Cardiomyocytes

Circulation2024-11-12

Abstract 10588: Pre-Clinical Study of Induced Pluripotent Stem Cell-Derived Cardiomyocyte Sheet Transplantation for a Cynomolgus Macaque Model of Doxorubicin-Induced Dilated Cardiomyopathy

Circulation2022-11-08

Case report: Transplantation of human induced pluripotent stem cell-derived cardiomyocyte patches for ischemic cardiomyopathy

Frontiers in Cardiovascular Medicine2022-08-1689 citations